SYSTEMIC LUPUS ERYTHEMATOSUS

Adverse reaction reported in 177,122 FDA reports across 31 drugs.

177,122
Total Reports
31
Drugs Involved
Infliximab
Most Reported Drug

Drugs Associated with SYSTEMIC LUPUS ERYTHEMATOSUS

Drugs where "SYSTEMIC LUPUS ERYTHEMATOSUS" was reported as an adverse event.

# Drug Reports % of Total
1 Infliximab 10,555
6.0%
2 Folic Acid 9,996
5.6%
3 Leflunomide 9,784
5.5%
4 Tocilizumab 9,555
5.4%
5 Rituximab 9,479
5.4%
6 Abatacept 9,318
5.3%
7 Alendronate 9,122
5.2%
8 Certolizumab Pegol 9,041
5.1%
9 Sulfasalazine 8,707
4.9%
10 Cetirizine 8,590
4.8%
11 Golimumab 8,434
4.8%
12 Desoximetasone 8,095
4.6%
13 Diclofenac 7,846
4.4%
14 Tofacitinib 7,005
4.0%
15 Cortisone 6,166
3.5%
16 Hydroxychloroquine 5,815
3.3%
17 Pseudoephedrine 5,246
3.0%
18 Adalimumab-Adaz 4,291
2.4%
19 Ustekinumab 4,131
2.3%
20 Adalimumab-Aaty 4,011
2.3%
21 Adalimumab-Fkjp 4,006
2.3%
22 Belimumab 3,858
2.2%
23 Cetiirizine 2,987
1.7%
24 Sarilumab 2,833
1.6%
25 Isopropyl Alcohol 1,580
0.9%
26 Alcohol 1,577
0.9%
27 Acetaminophen / Codeine 1,415
0.8%
28 Gluconate 1,212
0.7%
29 Triamcinolone Acetonide 1,144
0.6%
30 Triamcinolone Acetonide Ointment Usp, 0.05% 1,141
0.6%
31 Voclosporin 182
0.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused systemic lupus erythematosus. Always consult your healthcare provider.